Quest Diagnostics (DGX) Asset Writedowns and Impairment (2009 - 2019)

Quest Diagnostics has disclosed Asset Writedowns and Impairment across 11 years of filings, most recently posting $2.0 million for Q4 2019.

• Asset Writedowns and Impairment for Q4 2019 came in at $2.0 million, down 50.0% year-over-year; the trailing twelve-month figure through Dec 2019 was $11.0 million (up 83.33% YoY), and the FY2024 annual result was $5.0 million, up 400.0% from the prior year.
• Asset Writedowns and Impairment came in at $2.0 million for Q4 2019 at Quest Diagnostics, down from $4.0 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $86.0 million in Q1 2016 to a low of -$235.0 million in Q4 2016.
• The 5-year median for Asset Writedowns and Impairment is $3.5 million (2017), against an average of $16.4 million.
• Across the five-year window, Asset Writedowns and Impairment sank 461.54% in 2016 and soared 133.33% in 2019, its largest moves.
• Quest Diagnostics' Asset Writedowns and Impairment stood at $65.0 million in 2015, then tumbled by 461.54% to -$235.0 million in 2016, then jumped by 101.28% to $3.0 million in 2017, then surged by 33.33% to $4.0 million in 2018, then slumped by 50.0% to $2.0 million in 2019.
• The last three Asset Writedowns and Impairment figures came in at $2.0 million (Q4 2019), $4.0 million (Q3 2019), and $1.0 million (Q2 2019), per Business Quant data.